Identified by researchers at the Université de Montréal's IRCM.
Molecules show up to 25 times stronger activity against Ebola and SARS-CoV-2.
Potential implications for developing new antiviral treatments.
Identified by researchers at the Université de Montréal's IRCM.
Molecules show up to 25 times stronger activity against Ebola and SARS-CoV-2.
Potential implications for developing new antiviral treatments.